키움인베스트먼트, 600억 규모 첫 바이오 펀드 결성 [넘버스]

Kyoum Investment's launch of its first dedicated biotech fund signals intensified commitment to the bio-healthcare sector, which already represents 30% of its portfolio. The move positions the firm to join the symbolic 'AUM 1 trillion club' by year-end, a significant milestone in Korea's VC industry that could accelerate biotech investment ecosystem development.